In contrast, Kras;p53 mice with their extremely aggressive pancreatic tumor growth and subsequent rapid health deterioration, seem to react more unfavorably to the polyplexes and/or radioiodide treatment. This evidence concerns the gene TP53 and pancreatic neoplasm.